JoAnn Pinkerton, MD

Professor of obstetrics and gynecology and division director of Midlife Health at the University of Virginia Health System in Charlottesville, Virginia.

Articles

Switching from HRT to Non-HRT: Safety Considerations for Menopausal Women

January 17, 2025

An expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.

Non-Hormonal Therapy for Menopausal VMS: How Does Elinzanetant Differ from HRT?

January 13, 2025

JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program evaluating elinzanetant for menopausal VMS, discusses how non-hormonal therapy differs from HRT.

Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says

January 08, 2025

Less than 15% of women in menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.

Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician

January 06, 2025

Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.